Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: A comprehensive review

International Journal of Retina and Vitreous

Volumn 1, Issue 1, 2015, Pages

  Merani, Rohan ^a,b,c,d   Hunyor, Alex P ^a,b,c,e  

^a Retina Associates   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

^d ANZAC Research Institute   (Australia)

^e SYDNEY EYE HOSPITAL   (Australia)

Author keywords

Anti VEGF; Antibiotics; Antisepsis; Chlorhexidine; Endophthalmitis; Intravitreal injection; Masks; Povidone Iodine; Speculum; Streptococcus

Indexed keywords

EID: 84990311008     PISSN: None     EISSN: 20569920     Source Type: Journal    
DOI: 10.1186/s40942-015-0010-y     Document Type: Review

References (200)

1. Ramulu PY, Do DV, Corcoran KJ, Corcoran SL, Robin AL (2010) Use of Retinal procedures in medicare beneficiaries from 1997 to 2007. Arch Ophthalmol 128(10):1335-1340. doi: 10.1001/archophthalmol.2010.224
2. Murray TG (2012) Intravitreal Injection techniques: maximizing comfort and minimizing the risk of endophthalmitis. ASRS On-Demand Webinar 19 September 2012. Available at http://www.asrs.org/education/calendar/event/51/on-demand-webinar-intravitreal-injection-techniques-maximizing-comfort-and-minim. Accessed 22 Nov 2013
3. Campbell RJ, Bronskill SE, Bell CM, Paterson JM, Whitehead M, Gill SS (2010) Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis. Arch Ophthalmol 128(3):359-362. doi: 10.1001/archophthalmol.2010.19
4. Keenan TDL, Wotton CJ, Goldacre MJ (2012) Trends over time and geographical variation in rates of intravitreal injections in England. Br J Ophthalmol 96(3):413. doi: 10.1136/bjophthalmol-2011-300338
5. de Caro JJ, de Kaspar HM, Ta CN, Ho H-KV, Cabael L, Hu N et al (2008) Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections. Retina 28(6):877-883. doi: 10.1097/IAE.0b013e31816b3180
6. Moss JM, Sanislo SR, Ta CN (2010) Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections. Ophthalmology 117(11):2141-2145. doi: 10.1016/j.ophtha.2010.02.030
7. Stewart JM, Srivastava SK, Fung AE, Mahmoud TH, Telander DG, Hariprasad SM et al (2011) Bacterial contamination of needles used for intravitreal injections: a prospective multicenter study. Ocul Immunol Inflamm 19(1):32-38. doi: 10.3109/09273948.2010.520405
8. McCannel CA (2011) Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 31(4):654-661. doi: 10.1097/IAE.0b013e31820a67e4
9. Fileta JB, Scott IU, Flynn HW Jr (2014) Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthal Surg Laser Imaging Retina 45(2):143-149. doi: 10.3928/23258160-20140306-08
10. Nentwich M, Yactayo-Miranda Y, Weimann S, Froehlich S, Wolf A, Kampik A et al (2009) Bacterial contamination of needle points after intravitreal injection. Eur J Ophthalmol 19(2):268-272
11. Maxwell DP Jr, Brent BD, Orillac R, Baber WB, Mayeux PA (1993) A natural history study of experimental Staphylococcus epidermidis endophthalmitis. Curr Eye Res 12(10):907-912
12. Ranchod TM, Leverenz VR, Chintala SK, Cheng M, Trese MT, Giblin FJ (2010) Re: infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina 30(10):1752-1754. doi: 10.1097/IAE.0b013e3181fa4960(author reply 4)
13. Shockley RK, Jay WM, Fishman PH, Aziz MZ, Rissing JP (1985) Effect of inoculum size on the induction of endophthalmitis in aphakic rabbit eyes. Acta Ophthalmol Copenh 63(1):35-38
14. Simunovic MP, Rush RB, Hunyor AP, Chang AA (2012) Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 96(6):862-866. doi: 10.1136/bjophthalmol-2011-301439
15. Hoevenaars NE, Gans D, Missotten T, van Rooij J, Lesaffre E, van Meurs JC (2012) Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review. Ophthalmologica 228(3):143-147. doi: 10.1159/000339584
16. Storey P, Dollin M, Pitcher J, Reddy S, Vojtko J, Vander J et al (2014) The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Ophthalmology 121(1):283-289. doi: 10.1016/j.ophtha.2013.08.037
17. Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr, Schwartz SG, Davis JL, Murray TG et al (2011) Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center. Retina 31(4):662-668. doi: 10.1097/IAE.0b013e31821067c4
18. Chaudhary KM, Romero JM, Ezon I, Fastenberg DM, Deramo VA (2013) Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection. Retina 33(7):1407-1416. doi: 10.1097/IAE.0b013e3182807659
19. Casparis H, Wolfensberger TJ, Becker M, Eich G, Graf N, Ambresin A et al (2014) Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study. Retina 34(1):12-17. doi: 10.1097/IAE.0b013e31829f74b0
20. Klein KS, Walsh MK, Hassan TS, Halperin LS, Castellarin AA, Roth D et al (2009) Endophthalmitis after anti-VEGF injections. Ophthalmology 116(6):1225 e1. doi: 10.1016/j.ophtha.2009.02.031
21. Chen E, Lin MY, Cox J, Brown DM (2011) Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina 31(8):1525-1533. doi: 10.1097/IAE.0b013e318221594a
22. Fintak DR, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS et al (2008) Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 28(10):1395-1399. doi: 10.1097/IAE.0b013e3181884fd2
23. Brynskov T, Kemp H, Sorensen TL (2014) No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting. Retina 34(5):951-957. doi: 10.1097/IAE.0000000000000071
24. Bhavsar AR, Sandler DR (2015) Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon. Retina 35(4):783-788. doi: 10.1097/IAE.0000000000000392
25. Nentwich MM, Yactayo-Miranda Y, Schwarzbach F, Wolf A, Kampik A, de Kaspar HM (2014) Endophthalmitis after intravitreal injection: decreasing incidence and clinical outcome-8-year results from a tertiary ophthalmic referral center. Retina 34(5):943-950. doi: 10.1097/IAE.0000000000000011
26. Mithal K, Mathai A, Pathengay A, Jalali S, Relhan N, Motukupally SR et al (2013) Endophthalmitis following intravitreal anti-VEGF injections in ambulatory surgical centre facility: incidence, management and outcome. Br J Ophthalmol. doi: 10.1136/bjophthalmol-2013-303222
27. Shimada H, Hattori T, Mori R, Nakashizuka H, Fujita K, Yuzawa M (2013) Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask. Graefes Arch Clin Exp Ophthalmol 251(8):1885-1890. doi: 10.1007/s00417-013-2274-y
28. Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC (2012) Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 119(8):1609-1614. doi: 10.1016/j.ophtha.2012.02.014
29. Abell RG, Kerr NM, Allen P, Vote BJ (2012) Intravitreal injections: is there benefit for a theatre setting? Br J Ophthalmol 96(12):1474-1478. doi: 10.1136/bjophthalmol-2012-302030
30. Tabandeh H, Boscia F, Sborgia A, Ciraci L, Dayani P, Mariotti C et al (2014) Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. Retina 34(1):18-23. doi: 10.1097/IAE.0000000000000008
31. Pilli S, Kotsolis A, Spaide RF, Slakter J, Freund KB, Sorenson J et al (2008) Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol 145(5):879-882. doi: 10.1016/j.ajo.2007.12.036
32. Fineman MS, Hsu J, Spirn MJ, Kaiser RS (2013) Bimanual assisted eyelid retraction technique for intravitreal injections. Retina 33(9):1968-1970. doi: 10.1097/IAE.0b013e318287da92
33. Englander M, Chen TC, Paschalis EI, Miller JW, Kim IK (2013) Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. Br J Ophthalmol 97(4):460-465. doi: 10.1136/bjophthalmol-2012-302435
34. The American Society of Retina Specialists (ASRS) (2013) Preferences and trends (PAT) surveys. http://www.asrs.org/asrs-community/pat-survey. Accessed 17 Nov 2013
35. Doshi RR, Bakri SJ, Fung AE (2011) Intravitreal injection technique. Semin Ophthalmol. 26(3):104-113. doi: 10.3109/08820538.2010.541318
36. Ziemssen F, Wiedemann P, Kampik A, Holz F, Bartz-Schmidt KU (2009) Intravitreal injections of medications in Germany. Contract situation and legal conditions. Ophthalmologe 106(5):465-470. doi: 10.1007/s00347-009-1964-7
37. Barry P, Behrens-Baumann W, Uwe P, Seal D (2007) ESCRS guidelines on prevention, investigation and management of post-operative endophthalmitis. http://www.escrs.org/vienna2011/programme/handouts/IC-100/IC-100_Barry_Handout.pdf. Accessed 11 Nov 2013
38. Endophthalmitis Study Group ESoC (2007) Refractive S. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33(6):978-988. doi: 10.1016/j.jcrs.2007.02.032
39. Smalley KB, Warren JC, Klibert J (2012) Health risk behaviors in insured and uninsured community health center patients in the rural US South. Rural Remote Health 12:2123
40. Tanner J, Swarbrook S, Stuart J (2008) Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev 1:CD004288. doi: 10.1002/14651858.CD004288.pub2
41. Widmer AF, Rotter M, Voss A, Nthumba P, Allegranzi B, Boyce J et al (2010) Surgical hand preparation: state-of-the-art. J Hosp Infect 74(2):112-122. doi: 10.1016/j.jhin.2009.06.020
42. Rotter ML, Kampf G, Suchomel M, Kundi M (2007) Population kinetics of the skin flora on gloved hands following surgical hand disinfection with 3 propanol-based hand rubs: a prospective, randomized, double-blind trial. Infect Control Hosp Epidemiol 28(3):346-350. doi: 10.1086/510865
43. Huynh NT, Commens CA (2002) Scrubbing for cutaneous procedures can be hazardous. Australas J Dermatol 43(2):102-104
44. Pietsch H (2001) Hand antiseptics: rubs versus scrubs, alcoholic solutions versus alcoholic gels. J Hosp Infect 48(Suppl A):S33-S36
45. Grayson ML, Ballard SA, Gao W, Khumra S, Ward P, Johnson PD et al (2012) Quantitative efficacy of alcohol-based handrub against vancomycin-resistant enterococci on the hands of human volunteers. Infect Control Hosp Epidemiol 33(1):98-100. doi: 10.1086/663342
46. Ghorbani A, Shahrokhi A, Soltani Z, Molapour A, Shafikhani M (2012) Comparison of surgical hand scrub and alcohol surgical hand rub on reducing hand microbial burden. J Perioper Pract. 22(2):67-70
47. Saloojee H, Steenhoff A (2001) The health professional's role in preventing nosocomial infections. Postgrad Med J 77(903):16-19
48. Green-Simms AE, Ekdawi NS, Bakri SJ (2011) Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol 151(2):329-332. doi: 10.1016/j.ajo.2010.08.039
49. Shah SU, Koenig MJ, Dacquay Y, Mozayan A, Hubschman JP (2013) Assessment of the risk of needlestick injuries associated with intravitreal injections. Retina. doi: 10.1097/IAE.0b013e3182a2f523
50. Anijeet DR, Hanson RJ, Bhagey J, Bates RA (2007) National survey of the technique of intravitreal triamcinolone injection in the United Kingdom. Eye 21(4):480-486. doi: 10.1038/sj.eye.6702232
51. Hebl JR (2006) The importance and implications of aseptic techniques during regional anesthesia. Reg Anesth Pain Med 31(4):311-323. doi: 10.1016/j.rapm.2006.04.004
52. Miller KM, Apt L (1993) Unsuspected glove perforation during ophthalmic surgery. Arch Ophthalmol 111(2):186-193
53. Olsen RJ, Lynch P, Coyle MB, Cummings J, Bokete T, Stamm WE (1993) Examination gloves as barriers to hand contamination in clinical practice. JAMA 270(3):350-353
54. Stock C, Veyrier M, Raberin H, Fascia P, Rayet I, Lavocat MP et al (2012) Severe cutaneous aspergillosis in a premature neonate linked to nonsterile disposable glove contamination? Am J Infect Control 40(5):465-467. doi: 10.1016/j.ajic.2011.05.013
55. Bhavsar AR, Googe JM Jr, Stockdale CR, Bressler NM, Brucker AJ, Elman MJ et al (2009) Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol 127(12):1581-1583. doi: 10.1001/archophthalmol.2009.304
56. Kim SJ, Chomsky AS, Sternberg P Jr (2013) Reducing the risk of endophthalmitis after intravitreous injection. JAMA Ophthalmol 131(5):674-675. doi: 10.1001/jamaophthalmol.2013.2914
57. Flores A (2008) Sterile versus non-sterile glove use and aseptic technique. Nurs Stand. 23(6):35-39. doi: 10.7748/ns2008.10.23.6.35.c6707
58. Crompton DO (1961) Avoidance of the use of gloves during ophthalmic surgery. Trans Ophthalmol Soc Aust. 21:88-97
59. Perelman VS, Francis GJ, Rutledge T, Foote J, Martino F, Dranitsaris G (2004) Sterile versus nonsterile gloves for repair of uncomplicated lacerations in the emergency department: a randomized controlled trial. Ann Emerg Med 43(3):362-370. doi: 10.1016/S0196064403009697
60. Xia Y, Cho S, Greenway HT, Zelac DE, Kelley B (2011) Infection rates of wound repairs during Mohs micrographic surgery using sterile versus nonsterile gloves: a prospective randomized pilot study. Dermatol Surg 37(5):651-656. doi: 10.1111/j.1524-4725.2011.01949.x
61. Hepner DL (2006) Gloved and masked-will gowns be next? The role of asepsis during neuraxial instrumentation. Anesthesiology 105(2):241-243
62. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA et al (1994) Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 15(4 Pt 1):231-238
63. Alwitry A, Jackson E, Chen H, Holden R (2002) The use of surgical facemasks during cataract surgery: is it necessary? Br J Ophthalmol 86(9):975-977. doi: 10.1136/bjo.86.9.975
64. Moloney TP, Park J (2014) Microbiological isolates and antibiotic sensitivities in culture-proven endophthalmitis: a 15-year review. Br J Ophthalmol 98(11):1492-1497. doi: 10.1136/bjophthalmol-2014-305030
65. Facklam R (2002) What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15(4):613-630
66. Frandsen EV, Pedrazzoli V, Kilian M (1991) Ecology of viridans streptococci in the oral cavity and pharynx. Oral Microbiol Immunol 6(3):129-133
67. Kim SJ, Toma HS, Midha NK, Cherney EF, Recchia FM, Doherty TJ (2010) Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology 117(12):2372-2378. doi: 10.1016/j.ophtha.2010.03.034
68. Yin VT, Weisbrod DJ, Eng KT, Schwartz C, Kohly R, Mandelcorn E et al (2013) Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA Ophthalmol. 131(4):456-461. doi: 10.1001/jamaophthalmol.2013.2379
69. Moss JM, Sanislo SR, Ta CN (2009) A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 116(8):1498-1501. doi: 10.1016/j.ophtha.2009.02.024
70. Wen JC, McCannel CA, Mochon AB, Garner OB (2011) Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol 129(12):1551-1554. doi: 10.1001/archophthalmol.2011.227
71. Doshi RR, Leng T, Fung AE (2012) Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina. 32(3):473-476. doi: 10.1097/IAE.0B013E31822C2958
72. Friedman DA, Lindquist TP, Mason JO 3rd, McGwin G (2014) Needle contamination in the setting of intravitreal injections. Retina 34(5):929-934. doi: 10.1097/IAE.0000000000000067
73. Shewmaker PL, Gertz RE Jr, Kim CY, de Fijter S, DiOrio M, Moore MR et al (2010) Streptococcus salivarius meningitis case strain traced to oral flora of anesthesiologist. J Clin Microbiol 48(7):2589-2591. doi: 10.1128/JCM.00426-10
74. Trautmann M, Lepper PM, Schmitz FJ (2002) Three cases of bacterial meningitis after spinal and epidural anesthesia. Eur J Clin Microbiol Infect Dis 21(1):43-45
75. Veringa E, van Belkum A, Schellekens H (1995) Iatrogenic meningitis by Streptococcus salivarius following lumbar puncture. J Hosp Infect 29(4):316-318
76. Baer ET (2006) Post-dural puncture bacterial meningitis. Anesthesiology 105(2):381-393
77. Coatsworth NR, Huntington PG, Giuffre B, Kotsiou G (2013) The doctor and the mask: iatrogenic septic arthritis caused by Streptoccocus mitis. Med J Aust 198(5):285-286
78. Reeves KD, Horvat RT (2010) Aerosolized alpha-hemolytic Streptococcus as a cause of knee sepsis after intra-articular injection: predisposing factors. Am J Phys Med Rehabil 89(1):77-82. doi: 10.1097/PHM.0b013e3181c1ee3c
79. Sherertz RJ, Reagan DR, Hampton KD, Robertson KL, Streed SA, Hoen HM et al (1996) A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med 124(6):539-547
80. Orr NW (1981) Is a mask necessary in the operating theatre? Ann R Coll Surg Engl 63(6):390-392
81. Tunevall TG (1991) Postoperative wound infections and surgical face masks: a controlled study. World J Surg. 15(3):383-387 (discussion 7-8)
82. Webster J, Croger S, Lister C, Doidge M, Terry MJ, Jones I (2010) Use of face masks by non-scrubbed operating room staff: a randomized controlled trial. ANZ J Surg. 80(3):169-173. doi: 10.1111/j.1445-2197.2009.05200.x
83. Philips BJ, Fergusson S, Armstrong P, Anderson FM, Wildsmith JA (1992) Surgical face masks are effective in reducing bacterial contamination caused by dispersal from the upper airway. Br J Anaesth 69(4):407-408
84. Kuriyan AE, Weiss KD, Flynn HW Jr, Smiddy WE, Berrocal AM, Albini TA et al (2014) Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes. Am J Ophthalmol 57(4):774-780 e1. doi: 10.1016/j.ajo.2013.12.026
85. Jacobs DJ, Leng T, Flynn HW Jr, Shi W, Miller D, Gedde SJ (2011) Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result. Clin Ophthalmol. 5:739-744. doi: 10.2147/OPTH.S17975
86. Leng T, Miller D, Flynn HW Jr, Jacobs DJ, Gedde SJ (2011) Delayed-onset bleb-associated endophthalmitis (1996-2008): causative organisms and visual acuity outcomes. Retina. 31(2):344-352. doi: 10.1097/IAE.0b013e3181e09810
87. Schimel AM, Scott IU, Flynn HW Jr (2011) Endophthalmitis after intravitreal injections: should the use of face masks be the standard of care? Arch Ophthalmol 129(12):1607-1609. doi: 10.1001/archophthalmol.2011.370
88. Kamalarajah S, Ling R, Silvestri G, Sharma NK, Cole MD, Cran G et al (2007) Presumed infectious endophthalmitis following cataract surgery in the UK: a case-control study of risk factors. Eye. 21(5):580-586. doi: 10.1038/sj.eye.6702368
89. Schachat AP, Rosenfeld PJ, Liesegang TJ, Stewart MW (2012) Endophthalmitis is not a "never event". Ophthalmology 119(8):1507-1508. doi: 10.1016/j.ophtha.2012.03.048
90. Wildsmith JA (1993) Face masks and spinal anaesthesia [reply]. Br J Anaesth 70(2):239
91. Schiff FS (1990) The shouting surgeon as a possible source of endophthalmitis. Ophthal Surg. 21(6):438-440
92. Ahmed Y, Scott IU, Pathengay A, Bawdekar A, Flynn HW Jr (2014) Povidone-iodine for endophthalmitis prophylaxis. Am J Ophthalmol 157(3):503-504. doi: 10.1016/j.ajo.2013.12.001
93. de Kaspar HM, Chang RT, Singh K, Egbert PR, Blumenkranz MS, Ta CN (2005) Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol. 123(2):161-165. doi: 10.1001/archopht.123.2.161
94. Barry AL, Fuchs PC, Brown SD (1999) Lack of effect of antibiotic resistance on susceptibility of microorganisms to chlorhexidine gluconate or povidone iodine. Euro J Clin Microbiol Infect Dis 18(12):920-921. doi: 10.1007/s100960050434
95. Anderson MJ, Horn ME, Lin YC, Parks PJ, Peterson ML (2010) Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens. Am J Infect Control 38(10):826-831. doi: 10.1016/j.ajic.2010.06.022
96. Ta CN (2004) Minimizing the risk of endophthalmitis following intravitreous injections. Retina. 24(5):699-705
97. Isenberg SJ, Apt L, Campeas D (2002) Ocular applications of povidone-iodine. Dermatology 204(Suppl 1):92-95. doi:57733
98. Apt L, Isenberg S, Yoshimori R, Paez JH (1984) Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol 102(5):728-729
99. Speaker MG, Menikoff JA (1991) Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 98(12):1769-1775
100. Wykoff CC, Flynn HW Jr, Han DP (2011) Allergy to povidone-iodine and cephalosporins: the clinical dilemma in ophthalmic use. Am J Ophthalmol 151(1):4-6. doi: 10.1016/j.ajo.2010.08.044
101. Coakley FV, Panicek DM (1997) Iodine allergy: an oyster without a pearl? AJR Am J Roentgenol 169(4):951-952. doi: 10.2214/ajr.169.4.9308442
102. Jiang J, Wu M, Shen T (2009) The toxic effect of different concentrations of povidone iodine on the rabbit's cornea. Cutan Ocul Toxicol 28(3):119-124. doi: 10.1080/15569520903080511
103. Wykoff CC, Flynn HW, Jr., Rosenfeld PJ (2011) Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics. Am J Ophthalmol 152(5):717-719 e2. doi: 10.1016/j.ajo.2011.07.002
104. Trost LW, Kivilcim M, Peyman GA, Aydin E, Kazi AA (2007) The effect of intravitreally injected povidone-iodine on Staphylococcus epidermidis in rabbit eyes. J Ocul Pharmacol Ther 23(1):70-77. doi: 10.1089/jop.2006.0076
105. Whitacre MM, Crockett RS (1990) Tolerance of intravitreal povidone-iodine in rabbit eyes. Curr Eye Res 9(8):725-732
106. Schabelman E, Witting M (2010) The relationship of radiocontrast, iodine, and seafood allergies: a medical myth exposed. J Emerg Med 39(5):701-707. doi: 10.1016/j.jemermed.2009.10.014
107. Safar A, Dellimore MC (2007) The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections. Int Ophthalmol 27(5):307-312. doi: 10.1007/s10792-007-9073-6
108. Aiello LP, Brucker AJ, Chang S, Cunningham ET Jr, D'Amico DJ, Flynn HW Jr et al (2004) Evolving guidelines for intravitreous injections. Retina 24(5 Suppl):S3-S19
109. Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, D'Amico DJ et al (2014) Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 34(Suppl 12):S1-S18. doi: 10.1097/IAE.0000000000000399
110. Ferguson AW, Scott JA, McGavigan J, Elton RA, McLean J, Schmidt U et al (2003) Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol 87(2):163-167
111. Berkelman RL, Holland BW, Anderson RL (1982) Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 15(4):635-639
112. Ta CN, Singh K, Egbert PR, de Kaspar HM (2008) Prospective comparative evaluation of povidone-iodine (10% for 5 minutes versus 5% for 1 minute) as prophylaxis for ophthalmic surgery. J Cataract Refract Surg 34(1):171-172. doi: 10.1016/j.jcrs.2007.08.035
113. van Rooij J, Boks AL, Sprenger A, Ossewaarde JM, van Meurs JC (2011) The concentration of povidone-iodine for preoperative disinfection: relation to endophthalmitis incidence. Am J Ophthalmol 152(2):321. doi: 10.1016/j.ajo.2011.03.036
114. Friedman DA, Mason JO 3rd, Emond T, McGwin G Jr (2013) Povidone-iodine contact time and lid speculum use during intravitreal injection. Retina. 33(5):975-981. doi: 10.1097/IAE.0b013e3182877585
115. Apt L, Isenberg SJ, Yoshimori R, Chang A, Lam GC, Wachler B et al (1995) The effect of povidone-iodine solution applied at the conclusion of ophthalmic surgery. Am J Ophthalmol 119(6):701-705
116. Houang ET, Gilmore OJ, Reid C, Shaw EJ (1976) Absence of bacterial resistance to povidone iodine. J Clin Pathol 29(8):752-755
117. Kunisada T, Yamada K, Oda S, Hara O (1997) Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology 195(Suppl 2):14-18
118. Hsu J, Gerstenblith AT, Garg SJ, Vander JF (2014) Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. Am J Ophthalmol. 157(3):514-518 e1. doi: 10.1016/j.ajo.2013.10.003
119. Emilson CG (1977) Susceptibility of various microorganisms to chlorhexidine. Scand J Dent Res 85(4):255-265
120. Barkana Y, Almer Z, Segal O, Lazarovitch Z, Avni I, Zadok D (2005) Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting. Acta Ophthalmol Scand 83(3):360-363. doi: 10.1111/j.1600-0420.2005.00414.x
121. Yokoyama Y, Makino S, Ibaraki N (2008) Comparison in effectiveness of sterilization between chlorhexidine gluconate and povidone-iodine. Nihon Ganka Gakkai Zasshi 112(2):148-151
122. Hamill MB, Osato MS, Wilhelmus KR (1984) Experimental evaluation of chlorhexidine gluconate for ocular antisepsis. Antimicrob Agents Chemother 26(6):793-796
123. Burstein NL (1980) Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Invest Ophthalmol Vis Sci 19(3):308-313
124. Gasset AR, Ishii Y (1975) Cytotoxicity of chlorhexidine. Can J Ophthalmol 10(1):98-100
125. Varley GA, Meisler DM, Benes SC, McMahon JT, Zakov ZN, Fryczkowski A (1990) Hibiclens keratopathy. A clinicopathologic case report. Cornea 9(4):341-346
126. Dart JK, Saw VP, Kilvington S (2009) Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 148(4):487-99 e2. doi: 10.1016/j.ajo.2009.06.009
127. Anders N, Wollensak J (1997) Inadvertent use of chlorhexidine instead of balanced salt solution for intraocular irrigation. J Cataract Refract Surg 23(6):959-962
128. Green K, Livingston V, Bowman K, Hull DS (1980) Chlorhexidine effects on corneal epithelium and endothelium. Arch Ophthalmol 98(7):1273-1278
129. Klebe S, Anders N, Wollensak J (1998) Inadvertent use of chlorhexidine as intraocular irrigation solution. J Cataract Refract Surg 24(6):729-730
130. Horner C, Mawer D, Wilcox M (2012) Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? J Antimicrob Chemother 67(11):2547-2559. doi: 10.1093/jac/dks284
131. Langgartner J, Linde HJ, Lehn N, Reng M, Scholmerich J, Gluck T (2004) Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters. Intensive Care Med 30(6):1081-1088. doi: 10.1007/s00134-004-2282-9
132. Guzel A, Ozekinci T, Ozkan U, Celik Y, Ceviz A, Belen D (2009) Evaluation of the skin flora after chlorhexidine and povidone-iodine preparation in neurosurgical practice. Surg Neurol 71(2):207-210. doi: 10.1016/j.surneu.2007.10.026(discussion 10)
133. Isenberg S, Apt L, Yoshimuri R (1983) Chemical preparation of the eye in ophthalmic surgery. I. Effect of conjunctival irrigation. Arch Ophthalmol 101(5):761-763
134. Boes DA, Lindquist TD, Fritsche TR, Kalina RE (1992) Effects of povidone-iodine chemical preparation and saline irrigation on the perilimbal flora. Ophthalmology 99(10):1569-1574
135. Page MA, Fraunfelder FW (2009) Safety, efficacy, and patient acceptability of lidocaine hydrochloride ophthalmic gel as a topical ocular anesthetic for use in ophthalmic procedures. Clin Ophthalmol. 3:601-609
136. Kozak I, Cheng L, Freeman WR (2005) Lidocaine gel anesthesia for intravitreal drug administration. Retina 25(8):994-998
137. Boden JH, Myers ML, Lee T, Bushley DM, Torres MF (2008) Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival. J Cataract Refract Surg 34(10):1773-1775. doi: 10.1016/j.jcrs.2008.05.056
138. Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D (2005) Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 139(6):983-987. doi: 10.1016/j.ajo.2005.01.025
139. Inman ZD, Anderson NG (2011) Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia. Retina 31(4):669-672. doi: 10.1097/IAE.0b013e3181ef463d
140. Doshi RR, Leng T, Fung AE (2011) Povidone-iodine before lidocaine gel anesthesia achieves surface antisepsis. Ophthal Surg Lasers Imaging. 42(4):346-349. doi: 10.3928/15428877-20110210-02
141. Dahl DE, Dahl T Jr, Lane G, Ferguson D (2008) Does lidocaine gel decrease the effectiveness of a povidone-iodine prep? Invest Ophthalmol Vis Sci 49(5):5629
142. Lad EM, Maltenfort MG, Leng T (2012) Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection. Ophthal Surg Lasers Imaging. 43(2):115-120. doi: 10.3928/15428877-20120119-01
143. Tustin A, Kim SJ, Chomsky A, Hubbard GB 3rd, Sheng J (2014) Antibacterial properties of 2% lidocaine and reduced rate of endophthalmitis after intravitreal injection. Retina 34(5):935-942. doi: 10.1097/IAE.0000000000000014
144. Scott IU, Flynn HW Jr (2007) Reducing the risk of endophthalmitis following intravitreal injections. Retina. 27(1):10-12. doi: 10.1097/IAE.0b013e3180307271
145. Isenberg SJ, Apt L, Yoshimori R, Khwarg S (1985) Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol 103(9):1340-1342
146. Ta CN, Egbert PR, Singh K, Shriver EM, Blumenkranz MS, de Kaspar HM (2002) Mino De H. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology. 109(11):2036-2040 (discussion 40-1)
147. Halachmi-Eyal O, Lang Y, Keness Y, Miron D (2009) Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. J Cataract Refract Surg 35(12):2109-2114. doi: 10.1016/j.jcrs.2009.06.038
148. Bhatt SS, Stepien KE, Joshi K (2011) Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina. 31(10):2032-2036. doi: 10.1097/IAE.0b013e31820f4b4f
149. Bhavsar AR, Stockdale CR, Ferris FL 3rd, Brucker AJ, Bressler NM, Glassman AR et al (2012) Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics. Arch Ophthalmol 130(6):809-810. doi: 10.1001/archophthalmol.2012.227
150. Falavarjani KG, Modarres M, Hashemi M, Parvaresh MM, Naseripour M, Zare-Moghaddam A et al (2013) Incidence of acute endophthalmitis after intravitreal bevacizumab injection in a single clinical center. Retina 33(5):971-974. doi: 10.1097/IAE.0b013e31826f0675
151. Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn HW Jr (2006) In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol 124(4):479-483. doi: 10.1001/archopht.124.4.479
152. Schimel AM, Miller D, Flynn HW (2012) Evolving fluoroquinolone resistance among coagulase-negative Staphylococcus isolates causing endophthalmitis. Arch Ophthalmol 130(12):1617-1618. doi: 10.1001/archophthalmol.2012.2348
153. Schimel AM, Miller D, Flynn HW Jr (2013) Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol 156(1):50-52 e1. doi: 10.1016/j.ajo.2013.01.027
154. Kim SJ, Toma HS (2011) Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology 118(7):1358-1363. doi: 10.1016/j.ophtha.2010.12.014
155. Kim SJ, Toma HS (2011) Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. Arch Ophthalmol 129(9):1180-1188. doi: 10.1001/archophthalmol.2011.213
156. Dave SB, Toma HS, Kim SJ (2011) Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study. Ophthalmology 118(10):2035-2040. doi: 10.1016/j.ophtha.2011.03.017
157. Milder E, Vander J, Shah C, Garg S (2012) Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology 119(7):1420-1424. doi: 10.1016/j.ophtha.2012.01.016
158. Mino De Kaspar H, Hoepfner AS, Engelbert M, Thiel M, Ta CN, Mette M et al (2001) Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model. Ophthalmology 108(3):470-478
159. Dave SB, Toma HS, Kim SJ (2013) Changes in ocular flora in eyes exposed to ophthalmic antibiotics. Ophthalmology 120(5):937-941. doi: 10.1016/j.ophtha.2012.11.005
160. Yalvac IS, Basci NE, Bozkurt A, Duman S (2003) Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous. J Cataract Refract Surg 29(3):487-491. doi: 10.1016/S0886-3350(02)01538-9
161. Costello P, Bakri SJ, Beer PM, Singh RJ, Falk NS, Peters GB et al (2006) Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina 26(2):191-195
162. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, Group VISiONCT (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351(27):2805-2816. doi: 10.1056/NEJMoa042760
163. Principe AH (2008) Update on intravitreal injections. Tech Ophthalmol 6(3):83-87
164. Tailor R, Beasley R, Yang Y, Narendran N (2011) Evaluation of patients' experiences at different stages of the intravitreal injection procedure-what can be improved? Clin Ophthalmol 5:1499-1502. doi: 10.2147/OPTH.S24358
165. Stewart MW (2014) To the Editor. Retina 34(4):e11-e13
166. Shrier EM (2014) Cotton-tip applicator lid retraction technique for controlled intravitreal injection. Retina. 34(6):1244-1246. doi: 10.1097/IAE.0000000000000219
167. Mason RW (2013) Use of a desmarres retractor for upper lid and lash isolation during intravitreal injections. Retina 33(10):2175-2176. doi: 10.1097/IAE.0b013e3182999a1b
168. Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA et al (2011) Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 118(10):2028-2034. doi: 10.1016/j.ophtha.2011.02.034
169. Usman Saeed M, Batra R, Qureshi F, Clark D (2011) Reflux of drug during intra-vitreal anti-VEGF therapies. Semin Ophthalmol 26(6):357-360. doi: 10.3109/08820538.2011.588648
170. Cortez RT, Ramirez G, Collet L, Thakuria P, Giuliari GP (2010) Intravitreous bevacizumab injection: an experimental study in New Zealand white rabbits. Arch Ophthalmol 128(7):884-887. doi: 10.1001/archophthalmol.2010.139
171. Christoforidis JB, Williams MM, Epitropoulos FM, Knopp MV (2013) Subconjunctival bleb that forms at the injection site after intravitreal injection is drug, not vitreous. Clin Experiment Ophthalmol 41(6):614-615. doi: 10.1111/ceo.12074
172. Brodie FL, Ruggiero J, Ghodasra DH, Hui JZ, VanderBeek BL, Brucker AJ (2014) Volume and composition of reflux after intravitreal injection. Retina. 34(7):1473-1476. doi: 10.1097/IAE.0000000000000098
173. Saeed MU, Qureshi F, Batra R, Clark D (2011) Effect of reflux of drug during intravitreal anti-VEGF therapies on foveal thickness. Semin Ophthalmol. 26(2):61-63. doi: 10.3109/08820538.2011.559518
174. Chen SD, Mohammed Q, Bowling B, Patel CK (2004) Vitreous wick syndrome-a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana. Am J Ophthalmol. 137(6):1159-1160. doi: 10.1016/j.ajo.2004.01.028(author reply 60-1)
175. Turgut B, Demir T, Celiker U (2009) The effects of injection site on the reflux following intravitreal injections. J Clin Med Res. 1(5):280-284. doi: 10.4021/jocmr2009.12.1280
176. Cassar J, Smith T, Kwan T (2012) Intravitreal inoculation of cotton after bevacizumab (Avastin) injection. Arch Ophthalmol 130(1):126
177. Bdour MD, Ali ZR (2014) Intravitreal foreign body following intravitreal anti-VEGF injection: a case report. Eye 28(2):244-245. doi: 10.1038/eye.2013.250
178. Rodrigues EB, Meyer CH, Grumann A Jr, Shiroma H, Aguni JS, Farah ME (2007) Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am J Ophthalmol 143(6):1035-1037. doi: 10.1016/j.ajo.2007.01.035
179. Knecht PB, Michels S, Sturm V, Bosch MM, Menke MN (2009) Tunnelled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort. Retina. 29(8):1175-1181. doi: 10.1097/IAE.0b013e3181aade74
180. Ozkaya A, Alkin Z, Celik U, Yuksel K, Ozgurhan EB, Agca A et al (2013) Comparing the effects of three different intravitreal injection techniques on vitreous reflux and intraocular pressure. J Ocul Pharmacol Ther 29(3):325-329. doi: 10.1089/jop.2012.0144
181. Pulido JS, Pulido CM, Bakri SJ, McCannel CA, Cameron JD (2007) The use of 31-gauge needles and syringes for intraocular injections. Eye. 21(6):829-830. doi: 10.1038/sj.eye.6702514
182. Van Went C, Le Tien V, Mimoun G, Leveziel N, Parier V, Voigt M et al (2008) Comparison between 32 G vs 30 G needles used for intra vitreous injection (IVT). J Fr Ophtalmol 31(Supplement 1):99-100
183. Hubschman JP, Coffee RE, Bourges JL, Yu F, Schwartz SD (2010) Experimental model of intravitreal injection techniques. Retina. 30(1):167-173. doi: 10.1097/IAE.0b013e3181b094cf
184. Hoang QV, Jung JJ, Mrejen S, Freund KB (2014) Influence of axial length and postinjection reflux on sustained intraocular pressure elevation as a result of intravitreal anti-vascular endothelial growth factor therapy. Retina. 34(3):519-524. doi: 10.1097/IAE.0000000000000039
185. Pang CE, Mrejen S, Hoang QV, Sorenson JA, Freund KB (2015) Association between needle size, postinjection reflux, and intraocular pressure spikes after intravitreal injections. Retina. doi: 10.1097/IAE.0000000000000476
186. Centre for Disease Control and Prevention (2013) Injection safety: medication preparation questions. http://www.cdc.gov/injectionsafety/providers/provider_faqs_med-prep.html. Accessed 31 Oct 2013
187. Buckley T, Dudley SM, Donowitz LG (1994) Defining unnecessary disinfection procedures for single-dose and multiple-dose vials. Am J Crit Care 3(6):448-451
188. Hilliard JG, Cambronne ED, Kirsch JR, Aziz MF (2013) Barrier protection capacity of flip-top pharmaceutical vials. J Clin Anesth 25(3):177-180. doi: 10.1016/j.jclinane.2012.07.006
189. Tabatabaii A, Ahmadraji A, Khodabande A, Mansouri M (2013) Acute bilateral endophthalmitis following bilateral intravitreal bevacizumab (avastin) injection. Middle East Afr J Ophthalmol 20(1):87-88. doi: 10.4103/0974-9233.106402
190. Bakri SJ, Risco M, Edwards AO, Pulido JS (2009) Bilateral simultaneous intravitreal injections in the office setting. Am J Ophthalmol 48(1):66-69 e1. doi: 10.1016/j.ajo.2009.02.013
191. Shah GY, Ambatipudi S, Fernandes M, Lakshmipathy M, Varma PV, Sachdeva V et al (2010) We congratulate the authors for publishing their data on bilateral consecutive intravitreal injections administered in their office. Retina. 30(8):1325-1326. doi: 10.1097/IAE.0b013e3181e7985c(author reply 6-7)
192. Lima LH, Zweifel SA, Engelbert M, Sorenson JA, Slakter JS, Cooney MJ et al (2009) Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy. Retina. 29(9):1213-1217. doi: 10.1097/IAE.0b013e3181b32d27
193. Mahajan VB, Elkins KA, Russell SR, Boldt HC, Gehrs KM, Weingeist TA et al (2011) Bilateral intravitreal injection of antivascular endothelial growth factor therapy. Retina. 31(1):31-35. doi: 10.1097/IAE.0b013e3181ed8c80
194. Woo SJ, Han JM, Ahn J, Heo JW, Yu HG, Chung H et al (2012) Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance. Retina. 32(4):667-671. doi: 10.1097/IAE.0b013e31822c296b
195. Davis RP, Schefler AC, Murray TG (2010) Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration. Clin Ophthalmol. 4:703-707
196. Abu-Yaghi NE, Shokry AN, Abu-Sbeit RH (2014) Bilateral same-session intravitreal injections of anti-vascular endothelial growth factors. Int J Ophthalmol 7(6):1017-1021. doi: 10.3980/j.issn.2222-3959.2014.06.20
197. Chao DL, Gregori NZ, Khandji J, Goldhardt R (2014) Safety of bilateral intravitreal injections delivered in a teaching institution. Expert Opin Drug Deliv 11(7):991-993. doi: 10.1517/17425247.2014.909806
198. Goldberg RA, Flynn HW, Isom RF, Miller D, Gonzalez S (2012) An outbreak of Streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol 53(2):204-208.e1. doi: 10.1016/j.ajo.2011.11.035
199. Moshfeghi AA (2011) Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Semin Ophthalmol 26(3):139-148. doi: 10.3109/08820538.2011.570847
200. Schachat AP (2014) Simultaneous bilateral endophthalmitis after immediate sequential bilateral cataract surgery: what's the risk of functional blindness? Am J Ophthalmol 158(2):410-411. doi: 10.1016/j.ajo.2014.05.008